Overexpression of enhance of Zeste homolog 2 (EZH2) in endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group Study

OBJECTIVES: Enhancer of zeste homolog 2 (EZH2) is a histone methyl transferase that mediates epigenetic silencing of tumor suppressor genes. It is commonly over-expressed in several solid tumors and has been shown to be a prognostic biomarker. We investigated patterns of EZH2 expression in endometri...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gynecol Oncol
Autors principals: Krill, Lauren, Deng, Wei, Eskander, Ramez, Mutch, David, Zweizig, Susan, Hoang, Bang, Ioffe, Olga, Randall, Leslie, Lankes, Heather, Miller, David S., Birrer, Michael
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7103063/
https://ncbi.nlm.nih.gov/pubmed/31843273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2019.12.003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars